These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Plasma proteins in acute and chronic lung disease of the newborn. Moison RM; Haasnoot AA; Van Zoeren-Grobben D; Berger HM Free Radic Biol Med; 1998 Aug; 25(3):321-8. PubMed ID: 9680178 [TBL] [Abstract][Full Text] [Related]
4. Markers of oxidative stress and antioxidant activity in plasma and erythrocytes in neonatal respiratory distress syndrome. van Zoeren-Grobben D; Lindeman JH; Houdkamp E; Moison RM; Wijnen JT; Berger HM Acta Paediatr; 1997 Dec; 86(12):1356-62. PubMed ID: 9475316 [TBL] [Abstract][Full Text] [Related]
5. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915 [TBL] [Abstract][Full Text] [Related]
6. Vitamin E and selenium levels of premature infants with severe respiratory distress syndrome and bronchopulmonary dysplasia. Falciglia HS; Ginn-Pease ME; Falciglia GA; Lubin AH; Frank DJ; Chang W J Pediatr Perinat Nutr; 1988; 2(1):35-49. PubMed ID: 3216334 [No Abstract] [Full Text] [Related]
7. Plasma gelsolin levels in the diagnosis, prognosis, and treatment of lung complications of prematurity. DiNubile MJ Am J Respir Crit Care Med; 2012 Dec; 186(11):1195-6. PubMed ID: 23204381 [No Abstract] [Full Text] [Related]
8. Red blood cell glutathione and plasma sulfhydryls in chronic lung disease of the newborn. Moison RM; Haasnoot AA; van Zoeren-Grobben D; Berger HM Acta Paediatr; 1997 Dec; 86(12):1363-9. PubMed ID: 9475317 [TBL] [Abstract][Full Text] [Related]
9. Update on the diagnosis and management of bronchopulmonary dysplasia/chronic lung disease of infancy: what the radiologist should know. Parad RB Pediatr Radiol; 2012 Jan; 42 Suppl 1():S92-100. PubMed ID: 22395721 [TBL] [Abstract][Full Text] [Related]
10. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Stevens TP; Blennow M; Soll RF Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470 [TBL] [Abstract][Full Text] [Related]
11. Positive end expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia. Bamat N; Millar D; Suh S; Kirpalani H Cochrane Database Syst Rev; 2012 Jan; 1():CD004500. PubMed ID: 22258957 [TBL] [Abstract][Full Text] [Related]
12. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Stevens TP; Blennow M; Soll RF Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469 [TBL] [Abstract][Full Text] [Related]